• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺素对静脉壁纤溶酶原激活物释放的体外刺激作用。

In vitro stimulation of plasminogen activator release from vein walls by adrenaline.

作者信息

Kjaeldgaard A, Kjaeldgaard M

出版信息

J Clin Pathol. 1986 Nov;39(11):1241-4. doi: 10.1136/jcp.39.11.1241.

DOI:10.1136/jcp.39.11.1241
PMID:3098801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1140771/
Abstract

The effect of adrenaline on plasminogen activator release was studied in vitro in human vein biopsy specimens, in which the fibrinolytic activity was determined according to the fibrin slide technique. The tissue slides were covered with a thin fibrin film containing 10(-9) and 10(-7) M adrenaline and exposed for 30 to 60 minutes. In both concentrations highly significant (p less than 0.001) enhancement of fibrinolytic activity was shown, and the enhancement of fibrinolysis was most pronounced during the first 30 minutes of exposure. Stimulation of fibrinolysis was maximal after exposure to the physiological concentration of 10(-9) M, while no further increase was seen using the pharmacological concentration. These results show that adrenaline has a stimulant effect on tissue fibrinolysis in vitro, and this effect may account for the direct stimulation of fibrinolysis by adrenaline in vivo.

摘要

在人体静脉活检标本中对肾上腺素对纤溶酶原激活物释放的影响进行了体外研究,其中根据纤维蛋白玻片技术测定纤溶活性。组织玻片覆盖有含10(-9)和10(-7)M肾上腺素的薄纤维蛋白膜,并暴露30至60分钟。在两种浓度下均显示出纤溶活性的高度显著增强(p小于0.001),并且在暴露的最初30分钟内纤溶增强最为明显。暴露于生理浓度10(-9)M后纤溶刺激最大,而使用药理浓度时未见进一步增加。这些结果表明,肾上腺素在体外对组织纤溶有刺激作用,并且这种作用可能解释了体内肾上腺素对纤溶的直接刺激。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ed/1140771/651af36ec809/jclinpath00319-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ed/1140771/651af36ec809/jclinpath00319-0079-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ed/1140771/651af36ec809/jclinpath00319-0079-a.jpg

相似文献

1
In vitro stimulation of plasminogen activator release from vein walls by adrenaline.肾上腺素对静脉壁纤溶酶原激活物释放的体外刺激作用。
J Clin Pathol. 1986 Nov;39(11):1241-4. doi: 10.1136/jcp.39.11.1241.
2
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
3
Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.血浆组织型纤溶酶原激活物可增强外源性尿激酶型纤溶酶原激活物的纤溶活性。
Blood Coagul Fibrinolysis. 2012 Dec;23(8):729-33. doi: 10.1097/MBC.0b013e32835897d5.
4
What drives "fibrinolysis"?是什么驱动了“纤维蛋白溶解”?
Hamostaseologie. 2015;35(4):303-10. doi: 10.5482/HAMO-14-10-0050. Epub 2015 Jan 7.
5
Long-term treatment with combined oral contraceptives and cigarette smoking associated with impaired activity of tissue plasminogen activator.口服复方避孕药长期治疗与吸烟会导致组织纤溶酶原激活物活性受损。
Acta Obstet Gynecol Scand. 1986;65(3):219-22. doi: 10.3109/00016348609155174.
6
TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.TM5275 延长了分泌型组织型纤溶酶原激活物的保留时间,并增强了血管内皮细胞的纤溶作用。
Thromb Res. 2013 Jul;132(1):100-5. doi: 10.1016/j.thromres.2013.04.003. Epub 2013 Apr 20.
7
Studies on the release of plasminogen activator.纤溶酶原激活剂释放的研究。
Thromb Res. 1976 Feb;8(2):217-23. doi: 10.1016/0049-3848(76)90264-4.
8
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
9
Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis.
Thromb Haemost. 1990 Jun 28;63(3):482-7.
10
The hemodynamic and fibrinolytic response to low dose epinephrine and phenylephrine infusions during total hip replacement under epidural anesthesia.在硬膜外麻醉下全髋关节置换术中,低剂量肾上腺素和去氧肾上腺素输注时的血流动力学和纤溶反应。
Thromb Haemost. 1992 Oct 5;68(4):436-41.

引用本文的文献

1
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States.纤溶抑制和低纤溶不是同义词:区分低纤溶状态的临床意义。
Semin Thromb Hemost. 2023 Jul;49(5):433-443. doi: 10.1055/s-0042-1758057. Epub 2022 Nov 1.
2
Potential Antithrombotic and Fibrinolytic Properties of the Angiotensin Converting Enzyme Inhibitors.血管紧张素转换酶抑制剂的潜在抗血栓形成和纤维蛋白溶解特性。
J Thromb Thrombolysis. 1995;1(3):251-257. doi: 10.1007/BF01060734.
3
Epinephrine exerts anticoagulant effects during human endotoxemia.

本文引用的文献

1
Fibrinolysis autographs.纤维蛋白溶解图谱
Nature. 1958 Feb 15;181(4607):495-6. doi: 10.1038/181495b0.
2
delta 4-ethylestrenol in recurrent deep venous thrombosis.复发性深静脉血栓形成中的δ-4-乙基雌烯醇
Acta Med Scand. 1981;209(1-2):45-9. doi: 10.1111/j.0954-6820.1981.tb11550.x.
3
Relationship between tissue plasminogen activator and the activators in blood and vascular wall.组织型纤溶酶原激活剂与血液及血管壁中的激活剂之间的关系。
肾上腺素在人类内毒素血症期间发挥抗凝作用。
J Exp Med. 1997 Mar 17;185(6):1143-8. doi: 10.1084/jem.185.6.1143.
4
Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?血管紧张素转换酶抑制剂——它们具有抗缺血作用吗?
Trans Am Clin Climatol Assoc. 1996;107:57-66; discussion 66-7.
Thromb Res. 1980 Jun 15;18(6):815-30. doi: 10.1016/0049-3848(80)90204-2.
4
Studies of the blood plasminogen activator induced by 1-desamino-8-D-arginine vasopressin with observations in von Willebrand's disease.1-去氨基-8-D-精氨酸加压素诱导的血浆纤溶酶原激活物的研究及对血管性血友病的观察
Proc Soc Exp Biol Med. 1982 Jun;170(2):126-32. doi: 10.3181/00379727-170-41407.
5
Plasminogen activator activity of superficial veins in acute deep venous thrombosis.急性深静脉血栓形成时浅表静脉的纤溶酶原激活物活性
Vasa. 1982;11(3):174-7.
6
Fibrinolytic activity in the walls of foot veins in women using combined contraceptive pills.使用复方避孕药的女性足部静脉壁中的纤溶活性。
Gynecol Obstet Invest. 1983;15(4):223-9. doi: 10.1159/000299414.
7
Immunological characterisation of plasminogen activators in the human vessel wall.人血管壁中纤溶酶原激活剂的免疫学特性分析
J Clin Pathol. 1983 Sep;36(9):1046-9. doi: 10.1136/jcp.36.9.1046.
8
Perfused rat hindlegs. A model to study plasminogen activator release.灌注大鼠后肢。一种用于研究纤溶酶原激活物释放的模型。
Thromb Res. 1983 May 1;30(3):195-203. doi: 10.1016/0049-3848(83)90072-5.
9
A possible mechanism of vasoactive agents on plasminogen activator release in isolated perfused pig ears.血管活性药物对离体灌注猪耳纤溶酶原激活物释放的可能作用机制。
Thromb Res. 1983 Jan 15;29(2):187-96. doi: 10.1016/0049-3848(83)90140-8.
10
Decreased fibrinolytic activity in human atherosclerotic vessels.人类动脉粥样硬化血管中纤维蛋白溶解活性降低。
Atherosclerosis. 1984 Jan;50(1):113-6. doi: 10.1016/0021-9150(84)90013-3.